Parker Institute for Cancer Immunotherapy
United States of America (USA)
1 October 2018 - 30 September 2019
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Parker Institute for Cancer Immunotherapy published between 1 October 2018 - 30 September 2019 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Research collaboration: Parker Institute for Cancer Immunotherapy is a research collaboration whose article contributions are accrued to its participating partner institutions.
Note: Articles may be assigned to more than one subject area.
| Count | Share |
|---|---|
| 33 | 2.12 |
Outputs by subject (Share)
| Subject | Count | Share | |
|---|---|---|---|
| Life Sciences | 33 | 2.12 | |
| Chemistry | 1 | 0.08 | |
Top articles by Altmetric score in current window
De novo mutations in mitochondrial DNA of iPSCs produce immunogenic neoepitopes in mice and humans
Nature Biotechnology
2019-08-19
1 October 2018 - 30 September 2019
International vs. domestic collaboration by Share
- 70.67% Domestic
- 29.33% International
Note: Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators by Share (59 total)
- Parker Institute for Cancer Immunotherapy, United States of America (USA)
- Domestic institution
-
National Institutes of Health (NIH), United States of America (USA)
(1.73)
-
California Institute of Technology (Caltech), United States of America (USA)
(1.67)
-
Oregon Health and Science University (OHSU), United States of America (USA)
(1)
-
Penn Medicine, United States of America (USA)
(0.96)
-
Cornell University, United States of America (USA)
(0.91)
-
Emory University, United States of America (USA)
(0.88)
-
Ludwig Collaborative Laboratory at MSK, United States of America (USA)
(0.79)
-
Swim Across America Laboratory at MSKCC, United States of America (USA)
(0.67)
-
Ludwig Cancer Research, United States of America (USA)
(0.67)
-
AbbVie Inc., United States of America (USA)
(0.62)
Top 10 international collaborators by Share (55 total)
- Parker Institute for Cancer Immunotherapy, United States of America (USA)
- Foreign institution
-
Monash University, Australia
(0.75)
-
University of Hamburg (UHH), Germany
(0.58)
-
University of Montreal (UdeM), Canada
(0.33)
-
Clinical Research Institute of Montreal (IRCM), Canada
(0.33)
-
University of Toronto (U of T), Canada
(0.33)
-
Immatics Biotechnologies GmbH, Germany
(0.30)
-
Garvan Institute of Medical Research, Australia
(0.29)
-
DZHK Partner Site Hamburg/Kiel/Lübeck, Germany
(0.28)
-
Australian National University (ANU), Australia
(0.27)
-
Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), China
(0.24)
Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.
Participating institutions
Parker Institute for Cancer Immunotherapy is a research collaboration whose article contributions are accrued to its participating partner institutions below.
- Memorial Sloan Kettering Cancer Center (MSKCC), United States of America (USA)
- Stanford Medicine, United States of America (USA)
- University of California, Los Angeles (UCLA), United States of America (USA)
- University of California, San Francisco (UCSF), United States of America (USA)
- University of Pennsylvania (Penn), United States of America (USA)
- The University of Texas MD Anderson Cancer Center, United States of America (USA)
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
